Scholar Rock is asking the U.S. Food and Drug Administration to approve apitegromab for people with spinal muscular atrophy.

The BridgeSwitch IC is a half-bridge motor driver of low RDSON FREDFET switches, controllers and drivers in a thermally efficient package. Sensorless feedback, fault reporting, and self and load ...

CAMBRIDGE, Mass. - Scholar Rock (NASDAQ: SRRK), a biopharmaceutical company with a market capitalization of $3.96 billion and an impressive 362.73% stock price surge over the past six months, ...

A software companion to BridgeSwitch motor-driver ICs controls and configures high-efficiency single- and three-phase BLDC ...

Regulators in the U.S. and the European Union agreed to review Biogen’s applications for approval of a higher dose Spinraza ...

Wood River City Council approved a $936,964.54 budget for Motor Fuel Tax fund expenditures for road maintenance and projects.

NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market ...

Power Integrations has released MotorXpert v3.0, a software package for controlling and configuring BLDC inverters that use BridgeSwitch motor-driver ICs. The software implements field-oriented ...

GaN technology offers advantages over traditional silicon-based devices, including higher efficiency and faster switching speeds, EPC said.

Power Integrations has announced MotorXpert v3.0, a software suite for configuration, control and sensing of BLDC inverters that utilise the company’s BridgeSwitch motor-driver ICs.

We are pleased to announce that our applications for the higher dose regimen of nusinersen are now under review in the US and Europe,” said Stephanie Fradette, Pharm.D., Head of the Neuromuscular ...

Biogen said the U.S. Food and Drug Administration has accepted its supplemental new-drug application, while the European Medicines Agency has validated its application, which confirms that the ...